Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014

Pre-Filled Syringes

27 Jan 2014 - 28 Jan 2014 - London, UK

Bookmark and Share

Registration for Annual Pre-Filled Syringes - 2014 is now open. With one of the most established European market leaders on this subject and the huge successes of their previous meetings, SMi will provide another great forum for new advances in this field. 

Now in its 6th year, the 2014 conference will bring together experts from a range of industry perspectives to discuss solutions and strategies within key issues such as syringe formulations for biosimilars and other biologics, extractables and leachables, primary packaging developments and filling and finishing. 

What’s new in 2014:

•         2 days, 20 speakers, 18 unique presentations;

•         Top-Ranked Speaker Faculty includes leading experts from Pfizer, GlaxoSmithKline, Merck, Boehringer Ingelheim, Ipsen, Roche, Novo Nordisk and many others. 

•         2 panel discussions hosted by Advait Badkar, Bioprocess R&D, Pfizer, Adam Woolley, CEO, ForthTox, Bobbijo Redler, Principal Scientist, Merck, Jason Creasy, Head of Extractables & Leachables Team, GlaxoSmithKline;

•         2 Interactive half-day post-conference workshops: Leachables & Extractables, hosted by Andrew Fieldon, Senior Consultant, Smithers Rapra, and Large Volume Injectors – Technologies, Strategies and Guidance, hosted by Stephen Augustyn, Head of Mechanical Engineering, Team Consulting;

•         £999 (Conference only) for the first 25 pharmaceutical companies;

•         Pre-Filled Syringes – 2014 is proud to be sponsored by BD, Schott, West and Zeon. 

Key reasons to attend:

  Learn about the latest regulatory updates from MHRA and FDA bodies

  Hear exclusive news on autoinjector technologies

  Hear about manufacturing of container integrity and reduction in leachables

  Expand your professional network, meet leading specialists within the industry

  Get a chance to introduce your company and its services to potential partners


  Organiser: SMi Group Ltd. 

 Contact: Julia Rotar, 

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos